Ledger.Open graph →
SEC Form D · filed February 14, 2022

Silver Creek Pharmaceuticals, Inc

Offering
$25.0M
Sold
$9.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

James D. Marks · San Francisco, CADirectorTimothy Throsby · San Francisco, CAExec · DirectorThomas J. Murtagh · San Francisco, CADirectorLakhmir D. Chawla · San Francisco, CAExecMark Agne · San Francisco, CADirectorKris D. Kuchenbecker · San Francisco, CAExecNick J. Taylor · San Francisco, CADirectorThomas J. Murtagh · San Francisco, CADirectorLakhmir D. Chawla · San Francisco, CAExecJames D. Marks · San Francisco, CADirectorMark Agne · San Francisco, CADirectorKris D. Kuchenbecker · San Francisco, CAExecNick J. Taylor · San Francisco, CADirectorTimothy Throsby · San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗